Cours Pasteur. Molecular Cancer Genetics. September 18-29, 2017
|
|
|
- Ann Hawkins
- 6 years ago
- Views:
Transcription
1 Cours Pasteur Molecular Cancer Genetics September 18-29, 2017 Directors François CLEMENT-BIDARD Co-director, Institut Curie Hospital Jean-Pierre VARTANIAN Co-director, Institut Pasteur PROGRAM
2 Molecular Cancer Genetics Room 4 & Laboratory ground floor (Building 09, Education center), Institut Pasteur, Paris - Week September 2017 Monday, September 18 9h15-10h00 Course presentation Register office and Education Center presentations 10h30-12h00 Cancer-causing genes: understanding the functions of oncogenes and tumor suppressor genes 14h00-16h00 Molecular cancer: pillars and keystones 16h15-17h00 Practical Work (PW) presentation: Tuesday, September 19 9h00-10h30 Endogenous DNA mutator enzymes 11h00-12h30 Genetic predisposition to cancer 13h30 Wednesday, September 20 9h00-10h30 Regulation of Cell Cycle progression and diseases 11h00-12h30 Oncogenic viruses and the origin of molecular cancer biology Jean-Pierre Vartanian (Institut Pasteur) Chloé Journo (ENS, Lyon) Jean-Christophe Pagès (EFS) Jean-Pierre Vartanian (Institut Pasteur) Pascal Pineau (Institut Pasteur) Group photo Florence Margottin-Goguet (Institut Cochin) Moshe Yaniv (Institut Pasteur)
3 Thursday, September 21 9h30-12h00 PW: 14h00-17h00 Free Friday, September 22 9h00-10h30 Mechanisms of genome maintenance during antigen receptor diversification 11h00-12h30 Cytokine and Inflammation Analysis of APOBEC3A induced Ludovic Deriano (Institut Pasteur) Jean-Marc Cavaillon (Institut Pasteur)
4 Molecular Cancer Genetics Institut Curie, Ecole Normale Supérieure (ENS) Paris - Week September 2017 Monday, September 25 (Salle "chez Marie", Institut 9h00-10h30 DNA repair & cancer Marc-Henri Stern (Institut Curie Research, INSERM U830) 10h30-12h00 Genetics & the metastatic process François-Clément Bidard Tuesday, September 26 (Salle "cour anglaise 1&2", level -1, Bâtiment de Biologie du Développement, Institut 9H00-10h30 Genetics & Ethics Guillermo Orsi (Institut Curie Research, CNRS UMR 3664) 10h45-12h15 Genetics of sarcomas Sarah Watson 14h00-15h30 Bioinformatics & interpretation of NGS Nicolas Servant (Institut Curie Research, INSERM U900) 15h30-17h00 Rare allele detection Olivier Lantz (Institut Curie Research, INSERM U932) Wednesday, September 27 (salle "cour anglaise 1&2", level -1, Bâtiment de Biologie du Développement, Institut 9h00-10h30 HPV insertion & cancer Alain Nicolas (Institut Curie Research, CNRS UMR 3244) 10h45-12h15 Cancer immunotherapy Vassili Soumelis (Institut Curie Research, INSERM U932) 14h00-15h30 Epigenetic & cancer Raphael Margueron (Institut Curie Research, CNRS UMR 3215) 15h30-17h00 Genomic instability and telomeres Arturo Londono (Institut Curie Research, CNRS UMR 3244)
5 Thursday, September 28 (salle "cour anglaise 1&2", level -1, Bâtiment de Biologie du Développement, Institut 9h00-10h30 Molecular genetics of acute leukemia Hugues de Thé (Collège de France / CNRS UMR 7212, INSERM U944) Friday, September 29 (Ecole Normale Supérieure) 9h00-10h00 Steps in biomarker development François-Clément Bidard 10h00-12h00 Journal club François-Clément Bidard 14h00-16h00 Evaluation
Cours Pasteur. Molecular Cancer Genetics. September 24 October 5, Directors Jean-Pierre VARTANIAN Institut Pasteur. Sarah WATSON Institut Curie
Cours Pasteur Molecular Cancer Genetics September 24 October 5, 2018 Directors Jean-Pierre VARTANIAN Institut Pasteur Sarah WATSON Institut Curie PROGRAM 2018-2019 Molecular Cancer Genetics Room 4 & Laboratory
3 rd course on BREAST CANCER: FROM CLINICS TO BIOLOGY June 19-23, 2017 Institut Curie - Training Unit - International Course
08/03/2017 Monday, june 19 th : Clinical management Chair: Roman Rouzier 10:15 Training Unit Welcome: practical aspects & coffee 10:30 11:15 11:15 11:45 Anne Vincent-Salomon & Roman Rouzier Mathilde His
1 st course Genome Instability & Human Disease - May
1 st course Genome Instability & Human Disease - May 9-13 2016 A Training Unit International Course - Open conferences (in blue) Monday, May 9 th 09:45 Training Unit Institut Curie Sarah Lambert & Aura
ADVANCED IMMUNOLOGY COURSE
ADVANCED IMMUNOLOGY COURSE 2017-2018 MASTERS (M2) OF UNIVERSITIES PARIS DESCARTES, PIERRE ET MARIE CURIE ET DIDEROT PROGRAM FROM NOVEMBER 13TH 2017 TO JANUARY 9TH 2018 ADVANCED IMMUNOLOGY COURSE 2017-2018
Pasteur course MODELING OF INFECTIOUS DISEASES
Pasteur course MODELING OF INFECTIOUS DISEASES PROGRAM 2017-2018 Modeling of Infectious Diseases 2017-2018 CO-DIRECTORS OF THE COURSE Pierre -Yves BOËLLE Université Pierre et Marie Curie Hôpital Saint
INNATE IMMUNITY and INFECTIOUS DISEASES
INNATE IMMUNITY and INFECTIOUS DISEASES April 10-25, 2017 PRELIMINARY INNATE IMMUNITY AND INFECTIOUS DISEASES COURSE (from April 10 to April 25, 2017) This two and half week long course offers lectures
Pasteur course INTERNATIONAL SCHOOL OF TRANSLATIONAL PSYCHIATRY TRANS- PSY
Pasteur course INTERNATIONAL SCHOOL OF TRANSLATIONAL PSYCHIATRY TRANS- PSY PROGRAM 2017-2018 INTERNATIONAL SCHOOL OF TRANSLATIONAL PSYCHIATRY TRANS- PSY JUNE 25 th JUNE 29 th, 2018 Course directors Aroldo
8 th course on NON-CODING GENOME February 13-20, 2019 Institut Curie - Training Unit - International Course
Wednesday, February 13 Non-coding genome and pervasive transcription Chairs: Antonin Morillon Sven Diederichs 11.30 12.30 Registration & LUNCH (sandwiches) 12.30 13.00 13.00 14.00 14.00 15.00 Antonin MORILLON
Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in lateonset Pompe disease patients
Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in lateonset Pompe disease patients Elisa Masat 1, Pascal Laforêt 1,2, Marie De Antonio 3, Guillaume Corre 4, Barbara Perniconi
Christophe Mérieux Conference: New Trends in Tumor Virology
Sunday 17 January 2010 17.30-18.00 Registration 18.00 Welcome Address Guy VERNET - Fondation Mérieux Fabien ZOULIM - INSERM Opening Session 18.00-19.30 Chaired by Christian Bréchot & Massimo Tommasino
CELL BIOLOGY - CLUTCH CH CANCER.
!! www.clutchprep.com CONCEPT: OVERVIEW OF CANCER Cancer is a disease which is primarily caused from misregulated cell division, which form There are two types of tumors - Benign tumors remain confined
Bivalent-chromatin and epigenetics alterations in Glioma
Bivalent-chromatin and epigenetics alterations in Glioma Philippe ARNAUD GReD CNRS 6293 - Clermont Universités- INSERM U1103 Clermont-Ferrand, FRANCE Forum de la Recherche en Cancérologie Auvergne-Rhône
LEVEL OF THE COURSE and ELIGIBILITY: PhD students, or other qualified candidates
CALL FOR APPLICATION for Institut Pasteur International Network Course 2017 «Infectious diseases pathogenesis in Asia/Pacific» at the Institut Pasteur of Shanghai COURSE DATE: 4 th May 2017 20 th May 2017
27-28 November, 2017 Paris, France Espace Saint-Martin
27-28 November, 2017 Paris, France Espace Saint-Martin 199 bis rue Saint-Martin, 75003 Paris Immuno-oncology research and the subsequent development of immunotherapies continue to progress rapidly. We
Clinical trials (1) Bill Friedewald. 12h : Lunch 12h : Lunch 12h : Lunch 12h : Lunch 12h : Lunch 14h
French School of Public Health Ecole des Hautes Etudes en Santé Publique Master of Public Health - Semester 3 Weeks 37 to 41: from Tuesday 8 th September to 6 th October 2009 Module Code 203, Core curriculum,
FULL-TIME STUDIES IN ENGLISH AT THE FACULTY OF MEDICINE, MEDICAL PROGRAM SECOND YEAR SCHEDULE FOR THE SECOND SEMESTER OF 2017/2018
FULL-TIME STUDIES IN ENGLISH AT THE FACULTY OF MEDICINE, MEDICAL PROGRAM SECOND YEAR SCHEDULE FOR THE SECOND SEMESTER OF 2017/2018 GROUP 1 (25 students) Students 1-13 group 1A Students 14-25 group 1B Monday
Ecole doctorale Biologie-Médecine. Programme
Ecole doctorale Biologie-Médecine Programme 2016-2017 Cancer September 2016 Prof. Dominique Belin, Dépt de Pathologie et immunologie, Prof. A.-P. Sappino, Division d Oncologie Proto-oncogenes network (Tyrosine
PROGRAMME AND REGISTRATION
Basel Seminars in Pathology and Genetics 019 Daily practice and future perspectives of molecular pathology PHOTO: BASEL TOURISMUS Postgraduate Course, June 8th 9th, 019 PROGRAMME AND REGISTRATION General
Frontiers in Biological Psychiatry. Course
Frontiers in Biological Psychiatry Course Academic year 2016-2017 Frontiers in Biological Psychiatry Course June 27 th July 1st, 2016 Course organizers Patricia GASPAR Paris, Stéphane JAMAIN Groupe hospitalier
Section D: The Molecular Biology of Cancer
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Section D: The Molecular Biology of Cancer 1. Cancer results from genetic changes that affect the cell cycle 2. Oncogene proteins and faulty
Patient Stratification and Precision Medicine in Pancreatic Cancer
Patient Stratification and Precision Medicine in Pancreatic Cancer 12èmes Journées November the 24th 2016 Piquemal David Core Business: RNA diagnostics A state of art platform & a 17-year expertise in
CDx in oncology Prof. Christophe Le Tourneau, MD, PhD FEAM Geneva September 27, 2018
CDx in oncology Prof. Christophe Le Tourneau, MD, PhD Institut Curie Paris & Saint-Cloud France Head, Department of Drug Development and Innovation (D 3 i) INSERM U900 Research unit Versailles Saint-Quentin-en-Yvelines
Cancer immunity and immunotherapy. General principles
1 Cancer immunity and immunotherapy Abul K. Abbas UCSF General principles 2 The immune system recognizes and reacts against cancers The immune response against tumors is often dominated by regulation or
4 th ONE-HEALTH COURSE. (Preliminary program)
4 th ONE-HEALTH COURSE (Preliminary program) 4-20 April 2016 Monday 4 April 2016 9h00-10h30 WEEK 1 WELCOME TO THE COURSE : PRESENTATION OF PROFESSORS AND STUDENTS Myriam ERMONVAL, Marc SAVEY & Noël TORDO
Clinical utility of precision medicine in oncology
Clinical utility of precision medicine in oncology Prof. Christophe Le Tourneau, MD, PhD Institut Curie Paris & Saint-Cloud France Head, Department of Drug Development and Innovation (D 3 i) INSERM U900
STRUCTURAL STUDIES OF THE HIV-1 PRE-INTEGRATION COMPLEX IN/LEDGF INTERACTION INHIBITORS
STRUCTURAL STUDIES OF THE HIV-1 PRE-INTEGRATION COMPLEX IN/LEDGF INTERACTION INHIBITORS Marc Ruff Laboratory of Integrated structural biology IGBMC, Illkirch, France ruff@igbmc.fr Schematic diagram of
DEVELOPMENT & PLASTICITY OF THE NERVOUS SYSTEM
PASTEUR COURSE DEVELOPMENT & PLASTICITY OF THE NERVOUS SYSTEM 1 ST PART: EVOLUTION AND DEVELOPMENT OF THE NERVOUS SYSTEM 2 ND PART: DEVELOPMENT, PLASTICITY AND PATHOLOGIES OF THE NERVOUS SYSTEM From S.E.
Chapter 9, Part 1: Biology of Cancer and Tumor Spread
PATHOPHYSIOLOGY Name Chapter 9, Part 1: Biology of Cancer and Tumor Spread I. Cancer Characteristics and Terminology Neoplasm new growth, involves the overgrowth of tissue to form a neoplastic mass (tumor).
ACADEMIC PROGRAMME DEPARTMENT OF ORTHOPAEDICS 6 TH FLOOR, A.O.T.C. 17 JULIE NOVEMBER 2013
ACADEMIC PROGRAMME DEPARTMENT OF ORTHOPAEDICS 6 TH FLOOR, A.O.T.C. 17 JULIE 2013 13 NOVEMBER 2013 JULY 2013 Wednesday 17 07:30 Pre-operative Planning 13:00 Consultant s Meeting Dr J du Toit Thursday 18
What s on at the One Stop Shop for Autism Fife in February
What s on at the One Stop Shop for Autism Fife in 2016... *Please note that some groups have changed please check the calendar each time you plan to attend the One Stop Shop to check what is on. If it
PHILOSOPHY AND CANCER
PHILOSOPHY AND CANCER April 28 th, 2016 IHPST 13 rue du Four, 75006 Paris Second Floor, conference room Organized by Lucie Laplane and Thomas Pradeu. Funded by IHPST, University Paris I Panthéon-Sorbonne
LITERA VALLEY ZEE SCHOOL, HOSUR
WORKSHEET PRACTICE & SUMMATIVE ASSESSMENT DATE SHEET And SCHOOL TIMINGS SEPTEMBER 2016 WORKSHEET PRACTICE AND SUMMATIVE ASSESSMENT SCHOOL TIMINGS SEPTEMBER 2016 Date Day Grade School Timings 19.09.16 Mon
Tumor suppressor genes D R. S H O S S E I N I - A S L
Tumor suppressor genes 1 D R. S H O S S E I N I - A S L What is a Tumor Suppressor Gene? 2 A tumor suppressor gene is a type of cancer gene that is created by loss-of function mutations. In contrast to
Exam Schedule Matrix: Spring 2017
Final examinations are held at the end of each term in accordance with the published scheduling matrix. INSTRUCTORS: Room assignments for non-standard course meetings, exam conflicts or makeup exams will
Preceptorship course in metastatic colorectal cancer management
SCIENTIFIC PROGRAMME Preceptorship course in metastatic colorectal cancer management, Centre Hépato-Biliaire General information Live educational preceptorship course dates The live educational preceptorship
Jean-Yves Pierga Medical Oncology Department & Circulating Biomarkers Lab, SIRIC, Institut Curie, Paris France
Circulating Tumor Cells in brain metastatic patients Jean-Yves Pierga Medical Oncology Department & Circulating Biomarkers Lab, SIRIC, Institut Curie, Paris France CTC and ctdna detection Cabel ( ) Pierga,
Bihong Zhao, M.D, Ph.D Department of Pathology
Bihong Zhao, M.D, Ph.D Department of Pathology 04-28-2009 Is tumor self or non-self? How are tumor antigens generated? What are they? How does immune system respond? Introduction Tumor Antigens/Categories
1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles:
Carcinogenesis 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Carcinogenesis Major Principles: 1. Nonlethal genetic damage is central to
EASL HCC SUMMIT 2018 FROM BASIC TO CLINICAL RESEARCH: HOW TO IMPROVE HCC CLINICAL CARE? 01 03, MARCH 2018 GENEVA, SWITZERLAND
EASL HCC SUMMIT 2018 FROM BASIC TO CLINICAL RESEARCH: HOW TO IMPROVE HCC CLINICAL CARE? 01 03, MARCH 2018 GENEVA, SWITZERLAND SCIENTIFIC ORGANISING COMMITTEE Alejandro Forner, Spain Peter Galle, Germany
Immunoadjuvant Properties of Oncolytic Schwarz Measles Virus
Immunoadjuvant Properties of Oncolytic Schwarz Measles Virus Dr Jean-François Fonteneau Institut de Recherche en Santé de l Université de Nantes INSERM UMR892, CNRS UMR6299 Nantes, France Anti-tumor Virotherapy
April 26 th April 29 th, 2017 Kibbutz Hagoshrim, Israel WEDNESDAY, APRIL 26, rd International Congress on Molecular Targeting Therapy
3 rd International Congress on Molecular Targeting Therapy April 26 th April 29 th, 2017 Kibbutz Hagoshrim, Israel WEDNESDAY, APRIL 26, 2017 Update: Mar. 12 14:00-21:00 Registration & Check-In 16:00-17:00
Human Genetics 542 Winter 2018 Syllabus
Human Genetics 542 Winter 2018 Syllabus Monday, Wednesday, and Friday 9 10 a.m. 5915 Buhl Course Director: Tony Antonellis Jan 3 rd Wed Mapping disease genes I: inheritance patterns and linkage analysis
ESEMeD/MHEDEA The European Study of the Epidemiology of Mental Disorders/Mental Health Disability : a
ESEMeD/MHEDEA 2000 - The European Study of the Epidemiology of Mental Disorders/Mental Health Disability : a European Assessment in the year 2000 (ESEMeD/MHEDEA 2000) Head : Kovess-Masfety Viviane, INSERM
Transformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture:
Transformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture: Spandana Baruah December, 2016 Cancer is defined as: «A disease caused
/ Contents. 1. A word from the director Introduction Training - 4 Academic programs - 4 Career prospects - 5
/DE P ART E ME NTD É T UDE S C OGNI T I VE S 2 0 1 6 2 0 1 7 / Contents 1. A word from the director - 2 2. Introduction - 3 3. Training - 4 Academic programs - 4 Career prospects - 5 4. Research - 5 Overview
Course Organizers: Neal Copeland, Ph.D., The Houston Methodist Research Institute Nancy Jenkins, Ph.D., The Houston Methodist Research Institute
Saturday, August 20 25 th ANNUAL SHORT COURSE ON EXPERIMENTAL MODELS OF HUMAN CANCER August 20-28, 2016 Course Organizers: Neal Copeland, Ph.D., The Houston Methodist Research Institute Nancy Jenkins,
CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
Human Genetics 542 Winter 2017 Syllabus
Human Genetics 542 Winter 2017 Syllabus Monday, Wednesday, and Friday 9 10 a.m. 5915 Buhl Course Director: Tony Antonellis Module I: Mapping and characterizing simple genetic diseases Jan 4 th Wed Mapping
TARGETS OF CYCLIN D1-CDK
TARGETS OF CYCLIN D1-CDK FIRST TARGET OF THE COMPLEX CYCLIN D-KINASI: prb, IS THE PRODUCT OF THE GENE CONFERRING SUSCEPTIBILITY TO RETINOBLASTOMA - ABSENT OR MUTATED IN SEVERAL HUMAN CANCERS - TRANSCRIPTIONL
TUESDAY, 18th OCTOBER, 2016 / DAY -2. THE SPENCER HOTEL Hall A Hall B (St. Lukes Hospital)
Legend: Keynote Educational Meet the Expert (MTE) Paediatric Psycho-Oncology () Opening/Closing Award Session Free Paper Session (FPS) Session Satellite SIOPe GA SIOP ABM Late Breaker Session Networking
Ludwig Presence at 2016 ASCO Annual Meeting
Ludwig Scientist(s) Affiliation(s) Session and Presentation Time Location Track Session Type/Title Presentation and/or Abstract Title Friday, June 3, 2016 Luisa Lina Villa Ludwig Sao Paulo 1:00pm - 3:15pm
IMMUNOTHERAPY IN THE TREATMENT OF CERVIX CANCER. Linda Mileshkin, Medical Oncologist Peter MacCallum Cancer Centre, Melbourne Australia
IMMUNOTHERAPY IN THE TREATMENT OF CERVIX CANCER Linda Mileshkin, Medical Oncologist Peter MacCallum Cancer Centre, Melbourne Australia Distinguishing self from non-self T cells trained in the thymus as
BIMM134 The Biology of Cancer SPRING 2015
BIMM134 The Biology of Cancer SPRING 2015 Lectures: CENTR 214 Tuesdays/Thursdays, March 31 June 4 8:00 9:20 AM Instructor: Eric Bennett, Ph.D. email - e1bennett@ucsd.edu Office Hours: Tuesday and Thursday
Cell Division 10/1/17. The Biology of Cancer. The Biology of Cancer. Week 6. Week 6
10/1/17 Week 6 Week 6 The Biology of Cancer The Biology of Cancer the cell cycle Complete Week 6A edx for Monday. control of cell cycle by specific genes/gene ac4vity Looking ahead: Student class presentations
Chapter 20 Lecture Outline
Chapter 20 Lecture Outline See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright 2016 McGraw-Hill Education. Permission required for reproduction
Exam Schedule Spring 2019 Tuesday, April 30th - Monday, May 6th
Exam Schedule Spring 2019 Tuesday, April 30th - Monday, May 6th 01.04.19 Final examinations are held at the end of each term in accordance with the published final exam scheduling matrix. The matrix provides
Report from the visiting committee
Section des Unités de recherche Report from the visiting committee Research unit : Groupe de recherche sur les maladies infectieuses et inflammatoires (GRII) University of Réunion February 2008 Section
Early Embryonic Development
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors 2. Receptors 3. Regulatory proteins Maternal
Circulating tumour DNA in breast cancer. Kathleen Burke, PhD Bioinformatics Postdoctoral Fellow Laboratory of Dr. Jorge Reis-Filho
Circulating tumour DNA in breast cancer Kathleen Burke, PhD Bioinformatics Postdoctoral Fellow Laboratory of Dr. Jorge Reis-Filho Conflicts of Interest I have no financial relationships to disclose I will
2010 PEER Summer Intern Program
2010 PEER Summer Intern Program Heidi Faison Outreach Director Pacific Earthquake Engineering Research Center Kick-off Meeting, Davis Hall June 1, 2010 What is PEER? a multidisciplinary, multi-institutional
Carcinogenesis. Carcinogenesis. 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples
Carcinogenesis 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Major Principles (cont d) 4. Principle targets of genetic damage: 4 classes
European Summer School
European Summer School Ønsker om deltagelse i nedenstående summerschool bedes fremsendt til undertegnede senest d.1/4 2008. Ansøgning på max 1 side, samt CV på max 1 side. Bestyrelsen vil herefter indstille
Isorce Nathalie, Testoni B., Luangsay S., Locatelli M., Zannetti C., Henry T., Hasan U., Zoulim F., Durantel D.
Activité antivirale de différents interférons (IFNs) et cytokines proinflammatoires dans des modèles pertinents d hépatocytes infectés par le virus de l hépatite B (HBV) Isorce Nathalie, Testoni B., Luangsay
Emergence of new ALK mutations at relapse of neuroblastoma
Emergence of new ALK mutations at relapse of neuroblastoma Gudrun Schleiermacher MD PhD Institut Curie, Paris JCO, in press Background Cancer : frequent secondary progression, resistance to conventional
Deregulation of signal transduction and cell cycle in Cancer
Deregulation of signal transduction and cell cycle in Cancer Tuangporn Suthiphongchai, Ph.D. Department of Biochemistry Faculty of Science, Mahidol University Email: tuangporn.sut@mahidol.ac.th Room Pr324
Research in viral hepatitis: the French ANRS experience
PARIS HEPATITIS CONFERENCE January 14-15, 2013 Research in viral hepatitis: the French ANRS experience Pr. Jean-François DELFRAISSY Director of ANRS Internal Medicine Department CHU Bicêtre Paris XI -
THE ROLE OF TARGETED THERAPY AND IMMUNOTHERAPY IN THE TREATMENT OF ADVANCED CERVIX CANCER
Gynecologic Cancer InterGroup Cervix Cancer Research Network THE ROLE OF TARGETED THERAPY AND IMMUNOTHERAPY IN THE TREATMENT OF ADVANCED CERVIX CANCER Linda Mileshkin, Medical Oncologist Peter MacCallum
Multistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
2009 DELPHE* Workshop in Infectious Diseases. August 10-14, Hanoi, Vietnam
2009 DELPHE* Workshop in Infectious Diseases August 10-14, Hanoi, Vietnam The National Institute of Hygiene & Epidemiology (NIHE) & Vabiotech (Company No. 1 for Vaccines and Biological Production) Monday
Molecular and Cell Biology of Cancer. Code: ECTS Credits: 6. Degree Type Year Semester Biomedical Sciences OT 4 0
2017/2018 Molecular and Cell Biology of Cancer Code: 101897 ECTS Credits: 6 Degree Type Year Semester 2501230 Biomedical Sciences OT 4 0 Contact Name: Carles Arús Caralto Email: Carles.Arus@uab.cat Other
Sunday Monday Tuesday Wednesday Thursday Friday Saturday Bereavement Support Group 10 11:30
COMPREHENSIVE CANCER CENTER Upcoming Programs Financial Resources During and After Treatment June 30 PaintFest America July 14 Artful Journeys October June 2016 Follow Us! Facebook: UAB Comprehensive Cancer
Day 0 Sunday, July 8: Arrivals. Day 1 Monday, July 9: Introduction, Fundamentals, and Germline Variation. *As of 6/29/18
AACR Integrative Molecular Epidemiology Workshop: Bridging Cancer Biology and Precision Medicine July 9-13, 2018 (*arrival July 8) Westin Copley Place, Boston Boston, Massachusetts *As of 6/29/18 Director:
French Networks for Sarcoma and GIST. O Mir, JY Blay
French Networks for Sarcoma and GIST O Mir, JY Blay Introduction Since 2009 a network of 26 reference multidisciplinary centers aiming to improve the quality of care for sarcoma patients in France was
TUESDAY, 18th OCTOBER, 2016 / DAY -2
Legend: Keynote Educational PODC Symposium Meet the Expert (MTE) Paediatric Psycho-Oncology () Opening/Closing Award Session Free Paper Session (FPS) Session Satellite Symposium SIOPe GA SIOP ABM Late
Pettit Center Figure Skating Schedule DECEMBER 2018
Pettit Center Figure Skating Schedule DECEMBER 2018 HIGHLIGHT / MARK SESSIONS YOU WISH TO CONTRACT Sessions are on West Rink unless otherwise noted; Schedule subject to change Date Session Time Notes Saturday,
Molecular Biology of Cancer. Code: ECTS Credits: 6. Degree Type Year Semester
2017/2018 Molecular Biology of Cancer Code: 100863 ECTS Credits: 6 Degree Type Year Semester 2500252 Biochemistry OT 4 0 Contact Name: Carles Arús Caralto Email: Carles.Arus@uab.cat Other comments on languages
Introduction to Cancer Biology
Introduction to Cancer Biology Robin Hesketh Multiple choice questions (choose the one correct answer from the five choices) Which ONE of the following is a tumour suppressor? a. AKT b. APC c. BCL2 d.
FOCIS goes South: ADVANCES IN TRANSLATIONAL AND CLINICAL IMMUNOLOGY
FOCIS Center of Excellence Millennium Institute on Immunology and Immunotherapy & The Federation of Clinical Immunology Societies, FOCIS WORKSHOP FOCIS goes South: ADVANCES IN TRANSLATIONAL AND CLINICAL
Frontiers in PREVENTION. Research November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA
N I N T H A N N UA L A A C R I N T E R N AT I O N A L CO N F E R E N C E Frontiers in CANCER PREVENTION PROGRAM AND PROCEEDINGS November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA Continuing
Molecular and Cell Biology of Cancer. Code: ECTS Credits: 6. Degree Type Year Semester Biomedical Sciences OT 4 0
2018/2019 Molecular and Cell Biology of Cancer Code: 101897 ECTS Credits: 6 Degree Type Year Semester 2501230 Biomedical Sciences OT 4 0 Contact Name: Carles Arús Caralto Email: Carles.Arus@uab.cat Other
Molecular Biology of Cancer. Code: ECTS Credits: 6. Degree Type Year Semester
2018/2019 Molecular Biology of Cancer Code: 100863 ECTS Credits: 6 Degree Type Year Semester 2500252 Biochemistry OT 4 0 Contact Name: Carles Arús Caralto Email: Carles.Arus@uab.cat Other comments on languages
Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011.
Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. Sophie Vaux, Anne Carbonne, Jean-Michel Thiolet, Vincent Jarlier, Bruno Coignard, the RAISIN and Expert Laboratories Group
The lymphoma-associated NPM-ALK oncogene elicits a p16ink4a/prb-dependent tumor-suppressive pathway. Blood Jun 16;117(24):
DNA Sequencing Publications Standard Sequencing 1 Carro MS et al. DEK Expression is controlled by E2F and deregulated in diverse tumor types. Cell Cycle. 2006 Jun;5(11) 2 Lassandro L et al. The DNA sequence
A national perspective: the French case
INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE Developing a novel approach to deliver better precision medicine in Europe SESSION II: ROLE OF GOVERNAMENTAL & REGULATORY BODIES A national perspective:
Beat the Cancer - Biomedical New Researches
English version Beat the Cancer - Biomedical New Researches «Cancer is a dreadful disease. When diagnosed with delay, it can cause suffering, despair, and sometimes can threaten your life. But, now, we
(*Next Generation Sequencing)
(*Next Generation Sequencing) Patricia Aguilar Martinez, MD, PhD CHU de Montpellier, FRANCE & ENERCA WP leader 6 th European Symposium on Rare Anaemias-1 st Dutch-Belgian meeting for patients and health
Lisburn City Council. Sports Services Unit Active Ageing Lisburn
Lisburn City Council Sports Services Unit Active Ageing Lisburn October 13th-December 12th 2014 Contact Details For further details on all classes contact the relevant centre; T: 028 9267 2121 E: leisureplex@lisburn.gov.uk
Cell Death and Cancer. SNC 2D Ms. Papaiconomou
Cell Death and Cancer SNC 2D Ms. Papaiconomou How do cells die? Necrosis Death due to unexpected and accidental cell damage. This is an unregulated cell death. Causes: toxins, radiation, trauma, lack of
Cancer Biology Syllabus BIO 311
Cancer Biology Syllabus BIO 311 Course Instructor: Dr. Roslyn N. Crowder Telephone: 484-365- 7570 Email: rcrowder@mail.med.upenn.edu Office Location: Science Building Room 334 Office Hours: TBA Textbooks:
- A cancer is an uncontrolled, independent proliferation of robust, healthy cells.
1 Cancer A. What is it? - A cancer is an uncontrolled, independent proliferation of robust, healthy cells. * In some the rate is fast; in others, slow; but in all cancers the cells never stop dividing.
609G: Concepts of Cancer Genetics and Treatments (3 credits)
Master of Chemical and Life Sciences Program College of Computer, Mathematical, and Natural Sciences 609G: Concepts of Cancer Genetics and Treatments (3 credits) Text books: Principles of Cancer Genetics,
Supplementary Figure, Tables and Note for: Mutations in GNAL cause primary torsion dystonia
Supplementary Figure, Tables and Note for: Mutations in GNAL cause primary torsion dystonia Tania Fuchs, Rachel Saunders-Pullman,, Ikuo Masuho 4, Marta San Luciano 5, Deborah Raymond, Stewart Factor 6,
OMICS Journals are welcoming Submissions
OMICS Journals are welcoming Submissions OMICS International welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best possible
Accepted Manuscript. Letter to the Editor. Reply to: From the CUPIC study: Great times are not coming (?)
Accepted Manuscript Letter to the Editor Reply to: From the CUPIC study: Great times are not coming (?) Christophe Hezode, Helene Fontaine, Yoann Barthe, Fabrice Carrat, Jean-Pierre Bronowicki PII: S0-()00-
LARGE JOINTS FHWEEK #46 TRAINING COURSE HIP & KNEE FACULTY:
FACULTY: P R J-Y. LAZENNEC P R L. VASTEL D R R. BORDEI D R M. BRAX D R O. BRINGER D R O. BRUNET D R F. CHALENCON D R V. GAUDIOT D R E. GARRON D R P. LECOUTEUR D R R. LIMOZIN D R CH. MICHAUT D R P-B. REY
PROGRAM RNA The Nineteenth Annual Meeting of the RNA Society Quebec City, Canada June 03 08, 2014
PROGRAM RNA 2014 The Nineteenth Annual Meeting of the RNA Society Quebec City, Canada June 03 08, 2014 (See room locations floor plan at the back of the book.) Tuesday June 3 14:00 20:00 Registration Foyer
Carriers of Haemophilia Information for patients
Carriers of Haemophilia Information for patients page 2 You have been given this leaflet to explain what being a carrier of haemophilia means and the screening tests which are available. What is haemophilia?
Trial Objectives immunogenicity safety
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens requires 3 DNA injections. Long term Results of the EV03/ANRS Vac20 Phase I/II Trial. Yves Levy, Kim Ellefsen, Wolfgang Stöehr, Pierre-Alexandre
Background 11/8/2011. Disclosure. Hereditary Periodic Fever Syndromes Mutations in Idiopathic Acute Recurrent Pericarditis.
Mutations in Idiopathic Acute Recurrent Pericarditis Disclosure I have no relevant financial relationships to disclose Guillaume Geri, Pierre Hausfater, Catherine Dodé, Zahir Amoura, Jean-Charles Piette,
Institute of Radiation Biology. Oncogenes and tumour suppressor genes DoReMi Course 2014
Institute of Radiation Biology Oncogenes and tumour suppressor genes DoReMi Course 2014 Hippocrates: Cause is systemic excess of black humor. Paracelsus challenges the humor theory. Suggests external